Linus Biotechnology
New Rochelle
About Linus Biotechnology
Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine. It is focuses on complex genomic diseases that helps provide clients with the technology for the analysis of genomic sequencing data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.6M
- Last round: Series Unknown (Aug 2024)
- Website: linusbio.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/linus-biotechnology-121026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.